Recent trials of antithrombotics in the management of patients with acute coronary syndromes
- Cite this article as:
- Harrington, R.A. Curr Cardiol Rep (1999) 1: 181. doi:10.1007/s11886-999-0020-1
This is an exciting time to practice acute care cardiology as the tools of molecular biology are being used to discover multiple new therapies that affect the thrombotic system and may offer real benefit to patients. Correspondingly, the tools of information technology offer the real possibility that these new therapies can be rapidly and definitively studied in large outcome trials. Continued biologic discovery, coupled with reliable clinical trials methodology should allow clinicians to offer patients and society therapies with proven benefits and understood risks.